IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
about
The Dynamic Role of the IL-33/ST2 Axis in Chronic Viral-infections: Alarming and Adjuvanting the Immune ResponseInvolvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosisCurrent Management of Alcoholic Hepatitis and Future TherapiesNovel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver HomeostasisMacrophages and Alcohol-Related Liver InflammationAlcohol's Effect on Host DefenseThe Role of Innate Immunity in Alcoholic Liver DiseaseHepatic non-parenchymal cells: Master regulators of alcoholic liver disease?Interactions between Myc and Mediators of Inflammation in Chronic Liver DiseasesUpdate on Alcoholic HepatitisInflammasomes in pancreatic physiology and diseaseEndoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseasesNew Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review ArticleCritical Roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: From Basic Science to Clinical TrialsTargeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic SteatohepatitisChronic alcohol consumption potentiates the development of diabetes through pancreatic β-cell dysfunctionAlcoholic hepatitis and HCV interactions in the modulation of liver diseaseNeurotropin suppresses inflammatory cytokine expression and cell death through suppression of NF-κB and JNK in hepatocytesIL-37 inhibits inflammasome activation and disease severity in murine aspergillosisEmerging concepts in alcoholic hepatitisProgression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.Refining anti-inflammatory therapy strategies for bronchopulmonary dysplasia.Interleukin-1 receptor antagonist expression is inversely associated with outcomes of hepatitis B-related acute-on-chronic liver failure.New drug targets for alcoholic liver disease.Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.Screening of surface markers on rat intestinal mucosa microfold cells by using laser capture microdissection combined with protein chip technology.A Mechanistic Review of Cell Death in Alcohol-Induced Liver Injury.New therapeutic targets in alcoholic hepatitis.Integrated Assessment of Diclofenac Biotransformation, Pharmacokinetics, and Omics-Based Toxicity in a Three-Dimensional Human Liver-Immunocompetent Coculture System.Fibrogenesis in alcoholic liver disease.Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical RelevanceGaps in Knowledge and Research Priorities for Alcoholic Hepatitis.Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis.Inhibition of heat shock protein 90 alleviates steatosis and macrophage activation in murine alcoholic liver injury.Hexokinase II binding to mitochondria is necessary for Kupffer cell activation and is potentiated by ethanol exposureActivation of N-methyl-d-aspartate receptor downregulates inflammasome activity and liver inflammation via a β-arrestin-2 pathwayRole of Mitochondria in Alcoholic Liver DiseaseSevere alcoholic hepatitis-current concepts, diagnosis and treatment options.Scropolioside B inhibits IL-1β and cytokines expression through NF-κB and inflammasome NLRP3 pathways.Pathobiology of liver fibrosis: a translational success story
P2860
Q26743383-4DFB9BE7-7151-4671-9FB8-8B7F5D8095E1Q26744390-1549589B-6E34-4C2F-B757-59648F61ABA5Q26746544-0A995A00-641D-4D33-9A21-BBA62B8CC78CQ26746997-EEBA7B17-AF56-4BC3-83E0-5E3D4407792CQ26771553-003A31CC-7280-4C57-814C-C87ABF95DB05Q26773204-1DFE5D03-371E-491E-B4FD-42B8F5F98979Q26773226-04281945-5055-4504-ACF8-EED8C9706AECQ26773296-3F28E34E-6289-49B3-B5CF-F2AE790C944CQ26778328-2F335C9A-6577-4AA8-A063-1FDE5656526BQ26779121-B4E5A388-64EB-48D7-9DDC-C372A54269FFQ27027483-B8DAF965-E430-405D-B91F-A6264A5A6D2CQ27027733-5847B783-D639-423C-BD61-BF3962E8984FQ28070168-B6AB0A67-A524-41CE-920F-1E2E9C7EBEFFQ28073542-A1DD6721-41A4-40C8-A217-C8D36BD318BAQ28077079-705E4F3F-BABC-4AFE-8871-BB55D26E54B6Q28082228-B0A213BF-DD14-457B-B3B5-DE91F4171D0EQ28084063-747CE050-02ED-4738-A56F-7994D13ECA13Q28542459-7190124B-49BF-45F8-B8E3-749EFB7D67DEQ28544789-7C436A65-E708-4581-842F-A473F24665EEQ30234425-73360826-2CC6-43F3-8ECE-FD605DF29FA2Q30375693-8E6AD474-76FC-44AD-9CDE-3E51F1DCC3B2Q33684200-8B611859-5110-48C1-BEAB-2AD14ADE9EA7Q33744626-3F8D26FC-8CDE-4310-9DAA-AF09F18D4B5CQ33746508-0604C759-691C-4FCC-9D15-D80351B3A8C6Q33755829-0830A90D-F719-4A66-A30D-7C2EE42C6A3EQ33756249-11591255-C9E0-4E0D-AB2D-C1766D2B7C38Q33756960-84546A06-FBAC-412D-921F-BEA1C723A075Q33757267-48B23B81-D521-4414-B127-E88638537C77Q33792887-4FD8EFCB-13FF-43DF-A1F2-FB36C38E460AQ33845463-83C874E8-C961-4AE9-BBED-DE7E5F897F4CQ33882332-B00B9F29-5508-442E-B76F-5D7AB457F708Q33903664-2B35B513-4E1E-40B2-870B-868773106D8AQ34214279-78D8E422-CF38-4E95-993D-43D289A8F98DQ34216745-4E166A28-F258-4F67-900C-34402AD7DB8AQ34249104-5EF90BE2-7897-4528-B8BA-1FE63BA2B1AEQ34295408-6EE28F2F-C312-4278-917A-0E93D7DB5177Q34377243-DC955030-2103-4253-83D2-E46FC35F0BFAQ34404386-5D0BECCE-922D-427B-9CCE-18C9DB454BF7Q34438283-3967FCC4-E10A-4A53-A8A9-6F6D3AA75035Q34462733-5E7E4B34-7D03-4A48-A214-06994F5E8060
P2860
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice
@ast
IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice
@en
IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice
@nl
type
label
IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice
@ast
IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice
@en
IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice
@nl
prefLabel
IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice
@ast
IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice
@en
IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice
@nl
P2093
P2860
P3181
P356
P1476
IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice
@en
P2093
Dora Lippai
Evelyn A. Kurt-Jones
Gyongyi Szabo
Jan Petrasek
Karen Kodys
Matthew Barrieau
Shashi Bala
So-Yun Min
Timea Csak
Victoria Menashy
P2860
P304
P3181
P356
10.1172/JCI60777
P407
P577
2012-10-01T00:00:00Z